IPERIONX LTD (IPX)
NASDAQMaterialsOther Precious MetalsSnapshot 2026-11-04
NASDAQMaterialsOther Precious MetalsSnapshot 2026-11-04
Research Workspace
Put IPX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Materials: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Strong demand for titanium products: Direct metric needs a verified mapping.
View ThesisThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 79% in its worst 12-month stretch.
View RiskIPX's titanium demand story has to keep compounding to justify the price. The market cycle is in a Mania phase, which adds risk. The stock is down 22% from its recent high. This drop suggests the market is repricing the core thesis. Our model puts the next-quarter miss probability near 42%. The primary pillar is under pressure due to unverified metrics. The thesis comparison is not yet verified. Peer multiples imply a price about 12% above where it trades. This read is provisional. The thesis is on watch.
Trailing returns as of 2026-11-04. IPX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 6 analysts currently covering IPX (as of Nov 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare IPX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| IPX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Materials (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put IPX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Lower feedstock costs enhance competitive positioning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.

Validation of production system confirms technological viability.

Validation supports scalability and market entry.

Expansion of production capacity aligns with growth strategy.

Strong demand and policy support enhance market outlook.